TECH SEC Filing News — Bio-Techne Corporation

Latest SEC filings for Bio-Techne Corporation (TECH) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-30.

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, a…
Sector: Healthcare Industry: Biotechnology Market Cap: $11.4B CIK: 842023
20
Total Filings
0
Bullish Classifications
0
Bearish Classifications
16
Insider Transactions
3
Material Events (8-K)
1
Periodic Reports
What you're looking at: Each item below is parsed from an actual SEC filing submitted by Bio-Techne Corporation. Form 4 = confirmed insider transaction · Form 144 = proposed sale notice · 8-K = material event (earnings, M&A, leadership change, etc.) · 10-Q / 10-K = quarterly / annual report.
TECH Filing Activity Snapshot 2026-07-30 — 2026-09-30
Insider Transactions (Form 4)
0 buys vs 0 sells
Insider buying and selling activity is balanced in this period.
Insider Transactions 16 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 16 filings in this group are Form 4s for Bio-Techne Corporation.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 16 insider filings shown, the breakdown is 10 option exercise and 6 compensation award. None of the classified filings involved a discretionary open-market trade, so this period says nothing about what insiders think of the price.

What each transaction type means

Option exercise ×10
The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.
Compensation award ×6
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Form 4 Option exercise Tax / Compensation Filing 2026-09-30

TECH insider Form 4 filed for equity award, exercise, or tax withholding

HIGGINS JOHN L (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 15,940 — —
F Tax withholding on vested shares 5,562 $72.51 $403.3K
M Option exercise derivative · Stock Options (Right to Buy) 15,940 — —
Filing: Form 4 (Insider Transaction) Insider: HIGGINS JOHN L (Director) Shares: 21,502
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-09-24

TECH insider Form 4 filed for equity award, exercise, or tax withholding

BAUMGARTNER ROBERT V (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 15,940 — —
F Tax withholding on vested shares 5,559 $72.55 $403.3K
M Option exercise derivative · Stock Options (Right to Buy) 15,940 — —
Filing: Form 4 (Insider Transaction) Insider: BAUMGARTNER ROBERT V (Director) Shares: 21,499
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-19

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Bohnen Shane (SVP - General Counsel) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Units 11,344 — —
A Compensation award derivative · Restricted Stock Units 18,432 — —
Filing: Form 4 (Insider Transaction) Insider: Bohnen Shane (SVP - General Counsel)
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-19

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Kelderman Kim (Director, Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Units 57,590 — —
A Compensation award derivative · Restricted Stock Units 93,582 — —
Filing: Form 4 (Insider Transaction) Insider: Kelderman Kim (Director, Chief Executive Officer)
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-19

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Hippel James (CFO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Units 22,438 — —
A Compensation award derivative · Restricted Stock Units 36,459 — —
Filing: Form 4 (Insider Transaction) Insider: Hippel James (CFO)
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-19

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Herr Amy E. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Units 1,381 — —
Filing: Form 4 (Insider Transaction) Insider: Herr Amy E. (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-19

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Geist William (PRESIDENT, PROTEIN SCIENCES) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Units 14,762 — —
A Compensation award derivative · Restricted Stock Units 23,985 — —
Filing: Form 4 (Insider Transaction) Insider: Geist William (PRESIDENT, PROTEIN SCIENCES)
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-08-19

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Crouse Steven C. (President - Diag & Spatial Bi) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award derivative · Restricted Stock Units 8,702 — —
A Compensation award derivative · Restricted Stock Units 14,140 — —
Filing: Form 4 (Insider Transaction) Insider: Crouse Steven C. (President - Diag & Spatial Bi)
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-08-18

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Kelderman Kim (Director, Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 21,470 — —
F Tax withholding on vested shares 10,821 $72.40 $783.4K
M Option exercise derivative · Performance Restricted Stock Units 554 — —
D Disposition to issuer derivative · Performance Restricted Stock Units 8,319 — —
D Disposition to issuer derivative · Performance Stock Options (Right to Buy) 22,389 — —
M Option exercise derivative · Performance Restricted Stock Units 588 — —
D Disposition to issuer derivative · Performance Restricted Stock Units 8,835 — —
D Disposition to issuer derivative · Performance Stock Options (Right to Buy) 24,324 — —
M Option exercise derivative · Restricted Stock Units 8,543 — —
M Option exercise derivative · Restricted Stock Units 11,785 — —
Filing: Form 4 (Insider Transaction) Insider: Kelderman Kim (Director, Chief Executive Officer) Shares: 32,291
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-08-18

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Hippel James (CFO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 9,779 — —
F Tax withholding on vested shares 4,310 $72.40 $312.0K
M Option exercise derivative · Performance Restricted Stock Units 866 — —
D Disposition to issuer derivative · Performance Restricted Stock Units 12,999 — —
D Disposition to issuer derivative · Performance Stock Options (Right to Buy) 34,982 — —
M Option exercise derivative · Restricted Stock Units 4,010 — —
M Option exercise derivative · Restricted Stock Units 4,903 — —
Filing: Form 4 (Insider Transaction) Insider: Hippel James (CFO) Shares: 14,089
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-08-18

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Geist William (PRESIDENT, PROTEIN SCIENCES) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 6,416 — —
F Tax withholding on vested shares 1,976 $72.40 $143.1K
M Option exercise derivative · Performance Restricted Stock Units 567 — —
D Disposition to issuer derivative · Performance Restricted Stock Units 8,507 — —
D Disposition to issuer derivative · Performance Stock Options (Right to Buy) 22,898 — —
M Option exercise derivative · Restricted Stock Units 2,623 — —
M Option exercise derivative · Restricted Stock Units 3,226 — —
Filing: Form 4 (Insider Transaction) Insider: Geist William (PRESIDENT, PROTEIN SCIENCES) Shares: 8,392
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-08-18

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Bohnen Shane (SVP - General Counsel) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 4,350 — —
F Tax withholding on vested shares 1,343 $72.40 $97.2K
M Option exercise derivative · Restricted Stock Units 49 — —
D Disposition to issuer derivative · Performance Stock Option (Right to Buy) 12,117 — —
M Option exercise derivative · Performance Restricted Stock Units 300 — —
D Disposition to issuer derivative · Performance Restricted Stock Units 4,502 — —
M Option exercise derivative · Restricted Stock Units 1,669 — —
M Option exercise derivative · Restricted Stock Units 2,332 — —
Filing: Form 4 (Insider Transaction) Insider: Bohnen Shane (SVP - General Counsel) Shares: 5,693
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-08-18

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Crouse Steven C. (President - Diag & Spatial Bi) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 5,423 — —
F Tax withholding on vested shares 1,947 $72.40 $141.0K
M Option exercise derivative · Restricted Stock Units 1,379 — —
M Option exercise derivative · Restricted Stock Units 1,868 — —
M Option exercise derivative · Restricted Stock Units 2,176 — —
Filing: Form 4 (Insider Transaction) Insider: Crouse Steven C. (President - Diag & Spatial Bi) Shares: 7,370
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-08-18

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Herr Amy E. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 589 — —
F Tax withholding on vested shares 213 $72.40 $15.4K
M Option exercise derivative · Restricted Stock Units 118 — —
M Option exercise derivative · Restricted Stock Units 160 — —
M Option exercise derivative · Restricted Stock Units 311 — —
Filing: Form 4 (Insider Transaction) Insider: Herr Amy E. (Director) Shares: 802
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-07-31

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Hippel James (CFO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 62,068 $47.60 $2.95M
F Tax withholding on vested shares 51,024 $72.03 $3.68M
M Option exercise derivative · Stock Options (Right to Buy) 62,068 — —
Filing: Form 4 (Insider Transaction) Insider: Hippel James (CFO) Shares: 113,092
View on SEC EDGAR → Open Filing Document →
Form 4 Option exercise Tax / Compensation Filing 2026-07-30

TECH insider Form 4 filed for equity award, exercise, or tax withholding

Kelderman Kim (Director, Chief Executive Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider converted options into shares. The exercise price was fixed when the options were granted, so the timing usually tracks an expiry schedule.

Transactions reported on this filing
Code Nature Shares Price Value
M Option exercise 35,000 $47.60 $1.67M
F Tax withholding on vested shares 28,686 $72.07 $2.07M
M Option exercise derivative · Stock Option (Right to Buy) 35,000 — —
Filing: Form 4 (Insider Transaction) Insider: Kelderman Kim (Director, Chief Executive Officer) Shares: 63,686
View on SEC EDGAR → Open Filing Document →
Material Events 3 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 3 in this period for Bio-Techne Corporation. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-23

TECH filed 8-K — material company event

BIO-TECHNE Corp filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-09-14

TECH filed 8-K — material company event

BIO-TECHNE Corp filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-08-12

TECH filed 8-K — material company event

BIO-TECHNE Corp filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Periodic Reports 1 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 annual report (10-K) for Bio-Techne Corporation.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-K Annual Report 2026-08-24

TECH filed Annual Report (10-K)

BIO-TECHNE Corp filed its annual report with the SEC. This report includes audited financial statements, business overview, risk factors, and management discussion.

Filing: 10-K (Annual Report)
View on SEC EDGAR → Open Filing Document →

How we classify Bio-Techne Corporation's filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on TECH. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — TECH SEC Filings

More Tools for TECH

TECH Full Stock Analysis TECH Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper TECH analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the TECH stock analysis page.

TECH Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer